Silver Spike Investment Corp. (SSIC)
NASDAQ: SSIC · IEX Real-Time Price · USD
10.96
+0.31 (2.91%)
At close: Apr 19, 2024, 3:58 PM
10.93
-0.03 (-0.27%)
After-hours: Apr 19, 2024, 5:25 PM EDT
Silver Spike Investment Market Cap
Silver Spike Investment has a market cap or net worth of $68.11 million as of April 19, 2024. Its market cap has increased by 29.09% in one year.
Market Cap
68.11M
Enterprise Value
-29.75B
1-Year Change
29.09%
Ranking
Category
Stock Price
$10.96
Market Cap Chart
Since the IPO on February 4, 2022, Silver Spike Investment's market cap has decreased from $85.01M to $68.11M, a decrease of -19.87%. That is a compound annual growth rate of -9.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 67.24M | 0.84% |
Apr 18, 2024 | 66.68M | 3.17% |
Apr 17, 2024 | 64.63M | 2.06% |
Apr 16, 2024 | 63.33M | 0.30% |
Apr 15, 2024 | 63.14M | 2.52% |
Apr 12, 2024 | 61.59M | -0.70% |
Apr 11, 2024 | 62.02M | 1.53% |
Apr 10, 2024 | 61.09M | -0.71% |
Apr 9, 2024 | 61.53M | 2.06% |
Apr 8, 2024 | 60.28M | -1.02% |
Apr 5, 2024 | 60.90M | -2.00% |
Apr 4, 2024 | 62.15M | 4.06% |
Apr 3, 2024 | 59.72M | -1.13% |
Apr 2, 2024 | 60.41M | 0.31% |
Apr 1, 2024 | 60.22M | 0.83% |
Mar 28, 2024 | 59.72M | -2.54% |
Mar 27, 2024 | 61.28M | 0.51% |
Mar 26, 2024 | 60.97M | 0.10% |
Mar 25, 2024 | 60.90M | - |
Mar 22, 2024 | 60.90M | 1.77% |
Mar 21, 2024 | 59.85M | -0.31% |
Mar 20, 2024 | 60.03M | -0.41% |
Mar 19, 2024 | 60.28M | -1.52% |
Mar 18, 2024 | 61.21M | -0.10% |
Mar 15, 2024 | 61.28M | 0.92% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Asensus Surgical | 68.73M |
MediciNova | 68.66M |
Regencell Bioscience Holdings | 67.93M |
Instil Bio | 67.71M |
Landos Biopharma | 67.38M |
Pro-Dex | 65.84M |
Cidara Therapeutics | 65.43M |
Tiziana Life Sciences | 64.38M |